Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort.

Maria Esther Molina-Montes, Maria-Jose Sanchez, Genevieve Buckland, H B as Bueno-de-Mesquita, Elisabete Weiderpass, Pilar Amiano, Petra A. Wark, Tilman Kuhn, Verena A. Katzke, Jose Maria Huerta, Eva Ardanaz, Jose Ramon Quiros, Aurelie Affret, Mathilde His, Marie Christine Boutron-Ruault, Petra P H Peeters, Weimin Ye, Malin Sund, Heiner Boeing, Khalid IqbalBodil Ohlsson, Emily Sonestedt, Anne Tjonneland, Kristina En Petersen, Ruth C. Travis, Guri Skeie, Claudia Agnoli, Salvatore Panico, Domenico Palli, Rosario Tumino, Carlotta Sacerdote, Heinz Freisling, Inge Huybrechts, Kim Overvad, Antonia Trichopoulou, Christina Bamia, Effie Vasilopoulou, Nick Wareham, Kay Tee Khaw, Amanda J. Cross, Heather A. Ward, Elio Riboli, Eric J. Duell

Research output: Contribution to journalArticle

Abstract

BACKGROUND: The Mediterranean diet (MD) has been proposed as a means for cancer prevention, but little evidence has been accrued regarding its potential to prevent pancreatic cancer. We investigated the association between the adherence to the MD and pancreatic cancer risk within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. METHODS: Over half a million participants from 10 European countries were followed up for over 11 years, after which 865 newly diagnosed exocrine pancreatic cancer cases were identified. Adherence to the MD was estimated through an adapted score without the alcohol component (arMED) to discount alcohol-related harmful effects. Cox proportional hazards regression models, stratified by age, sex and centre, and adjusted for energy intake, body mass index, smoking status, alcohol intake and diabetes status at recruitment, were used to estimate hazard ratios (HRs) associated with pancreatic cancer and their corresponding 95% confidence intervals (CIs). RESULTS: Adherence to the arMED score was not associated with risk of pancreatic cancer (HR high vs low adherence=0.99; 95% CI: 0.77-1.26, and HR per increments of two units in adherence to arMED=1.00; 95% CI: 0.94-1.06). There was no convincing evidence for heterogeneity by smoking status, body mass index, diabetes or European region. There was also no evidence of significant associations in analyses involving microscopically confirmed cases, plausible reporters of energy intake or other definitions of the MD pattern. CONCLUSIONS: A high adherence to the MD is not associated with pancreatic cancer risk in the EPIC study.
Original languageUndefined/Unknown
Pages (from-to)811-820
Number of pages10
JournalBritish Journal of Cancer
Volume116
Issue number6
DOIs
Publication statusPublished - Mar 1 2017

Cite this

Molina-Montes, M. E., Sanchez, M-J., Buckland, G., Bueno-de-Mesquita, H. B. A., Weiderpass, E., Amiano, P., Wark, P. A., Kuhn, T., Katzke, V. A., Huerta, J. M., Ardanaz, E., Quiros, J. R., Affret, A., His, M., Boutron-Ruault, M. C., Peeters, P. P. H., Ye, W., Sund, M., Boeing, H., ... Duell, E. J. (2017). Mediterranean diet and risk of pancreatic cancer in the European Prospective Investigation into Cancer and Nutrition cohort. British Journal of Cancer, 116(6), 811-820. https://doi.org/10.1038/bjc.2017.14